Asymchem Laboratories (Tianjin) Co., Ltd. (SHE:002821)

Market Cap	35.38B +39.4%
Revenue (ttm)	6.29B +12.8%
Net Income	1.04B +35.1%
EPS	2.86 +32.4%
Shares Out	359.72M
PE Ratio	35.15
Forward PE	27.69
Dividend	1.10 (1.09%)
Ex-Dividend Date	Jun 26, 2025

Volume	2,736,903
Average Volume	3,778,272
Open	103.01
Previous Close	103.45
Day's Range	100.51 - 103.80
52-Week Range	59.90 - 125.50
Beta	0.23
RSI	48.88
Earnings Date	Mar 31, 2026

About SHE:002821

Asymchem Laboratories (Tianjin) Co., Ltd. provides clinical stage CDMO, commercial stage CDMO, and emerging services in Mainland China and internationally. The company offers API solutions, such as small molecules, highly potent, carbapenems, glycans, peptides, oligonucleotides, and therapeutic enzymes; GMP, non-GMP, asymchem lab facilities and capabilities, commercial manufacturing, clinical manufacturing, separations, crystallization, fermentation, continuous FlowGMP, non-GMP, Asymchem lab facilities and capabilities, commercial manufacturing...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 1998
• Employees: 9,595
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 002821

Financial Performance

In 2024, SHE:002821's revenue was 5.80 billion, a decrease of -25.82% compared to the previous year's 7.83 billion. Earnings were 948.95 million, a decrease of -58.17%.